Moreover, the data suggest that targeting PCNA with these PCNA inhibitors may provide a novel approach for enhancing the efficacy of chemotherapy and radiation therapy in treatment of human prostate and lung cancers. The gene discussed is PCNA; the disease is lung carcinoma.